Troleandomycin

Major

Troleandomycin Everolimus Afinitor Increased everolimus exposure Details Troleandomycin Futibatinib Lytgobi Increased futibatinib exposure and increased risk of futibatinib-related adverse reactions Details Troleandomycin Irinotecan Camptosar Increased irinotecan exposure and an increased irinotecan active metabolite exposure Details Troleandomycin Irinotecan Injection Camptosar Increased irinotecan exposure and an increased irinotecan active metabolite exposure Details Troleandomycin Irinotecan Lipid Complex Injection Onivyde® Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Troleandomycin Ketoconazole Topical Extina® Foam Increased ketoconazole exposure and an increased risk of ketoconazole-related adverse reactions Details Troleandomycin Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Troleandomycin Leniolisib Joenja Increased leniolisib exposure Details Troleandomycin Levonorgestrel After banger Increased contraceptive exposure and an increased risk of intrahepatic cholestasis Details Troleandomycin Levonorgestrel Intrauterine System Kyleena Increased contraceptive exposure and an increased risk of intrahepatic cholestasis Details Troleandomycin Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Troleandomycin Lumateperone Caplyta Increased lumateperone exposure and an increased risk of lumateperone-related adverse reactions Details Troleandomycin Lurbinectedin Injection Zepzelca Increased lurbinectedin exposure and an increased risk of lurbinectedin-related adverse reactions Details Troleandomycin Macitentan Opsumit Increased macitentan exposure Details Troleandomycin Maraviroc Selzentry Increased maraviroc exposure Details Troleandomycin Methylergonovine Methergine Increased methylergonovine exposure and an increased risk of vasospasm, cerebral ischemia and/or ischemia of extremities Details Troleandomycin Mitapivat Aqvesme Increased mitapivat exposure and an increased risk of mitapivat-related adverse reactions Details Troleandomycin Nifedipine Adalat® Increased NIFEdipine exposure and an increased risk of hypotension, bradycardia, or acute renal injury Details

Moderate

Troleandomycin Diazepam Nasal Spray Valtoco Increased benzodiazepine toxicity (CNS depression, ataxia, lethargy) Details Troleandomycin Diazepam Rectal Diastat Increased benzodiazepine toxicity (CNS depression, ataxia, lethargy) Details Troleandomycin Dofetilide Tikosyn Increased dofetilide exposure Details Troleandomycin Hydrocortisone Ala-Cort Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Troleandomycin Hydrocortisone Injection A-Hydrocort® Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Troleandomycin Midazolam Nasal Spray Nayzilam Increased benzodiazepine toxicity (CNS depression, ataxia, lethargy) Details Troleandomycin Midazolam Injection Nayzilam Increased benzodiazepine toxicity (CNS depression, ataxia, lethargy) Details